Product: KLF6 Antibody
Catalog: DF13114
Description: Rabbit polyclonal antibody to KLF6
Application: WB
Reactivity: Human, Mouse, Rat
Prediction: Pig, Bovine, Sheep, Rabbit, Dog
Mol.Wt.: 43 kDa; 32kD(Calculated).
Uniprot: Q99612
RRID: AB_2846074

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:500-1:2000
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human,Mouse,Rat
Prediction:
Pig(80%), Bovine(80%), Sheep(80%), Rabbit(92%), Dog(80%)
Clonality:
Polyclonal
Specificity:
KLF6 Antibody detects endogenous levels of total KLF6.
RRID:
AB_2846074
Cite Format: Affinity Biosciences Cat# DF13114, RRID:AB_2846074.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Expression:
Q99612 KLF6_HUMAN:

Highly expressed in placenta followed by spleen, thymus, prostate, testis, small intestine and colon. Weakly expressed in pancreas, lung, liver, heart and skeletal muscle. Also expressed in fetal brain, spleen and thymus.

Sequence:
MDVLPMCSIFQELQIVHETGYFSALPSLEEYWQQTCLELERYLQSEPCYVSASEIKFDSQEDLWTKIILAREKKEESELKISSSPPEDTLISPSFCYNLETNSLNSDVSSESSDSSEELSPTAKFTSDPIGEVLVSSGKLSSSVTSTPPSSPELSREPSQLWGCVPGELPSPGKVRSGTSGKPGDKGNGDASPDGRRRVHRCHFNGCRKVYTKSSHLKAHQRTHTGEKPYRCSWEGCEWRFARSDELTRHFRKHTGAKPFKCSHCDRCFSRSDHLALHMKRHL

Predictions

Predictions:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Rabbit
92
Pig
80
Bovine
80
Sheep
80
Dog
80
Xenopus
73
Chicken
73
Horse
70
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - Q99612 As Substrate

Site PTM Type Enzyme
K66 Ubiquitination
T147 Phosphorylation
S150 Phosphorylation
S151 Phosphorylation
S171 Phosphorylation
S192 Phosphorylation
K209 Acetylation
K213 Acetylation
K218 Acetylation
T223 Phosphorylation
T225 Phosphorylation
K228 Acetylation
S233 Phosphorylation

Research Backgrounds

Function:

Transcriptional activator (By similarity). Binds a GC box motif. Could play a role in B-cell growth and development.

Subcellular Location:

Nucleus.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Tissue Specificity:

Highly expressed in placenta followed by spleen, thymus, prostate, testis, small intestine and colon. Weakly expressed in pancreas, lung, liver, heart and skeletal muscle. Also expressed in fetal brain, spleen and thymus.

Family&Domains:

The acidic N-terminal part may favor interaction with the basic domain of transcription factors.

The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. In KLF6, the motif is inactive.

Belongs to the krueppel C2H2-type zinc-finger protein family.

References

1). miR‑181a‑5p regulates the proliferation and apoptosis of glomerular mesangial cells by targeting KLF6. Experimental and Therapeutic Medicine, 2020 (PubMed: 32742352) [IF=2.7]

Application: WB    Species: human    Sample: glomerular mesangial cell

Figure 7.| miR‑181a‑5p may regulate human glomerular mesangial cell proliferation and apoptosis via the Wnt/β‑catenin signaling pathway. (A) The protein expression levels of the associated factors in different groups were assessed by western blot analysis and (B) the results quantified. **P<0.01, *P<0.05. miR,microRNA; KLF6, kruppel-like factor 6; cells were treated with miR mimics control NC, negative control (cells were treated with miR mimics control).

2). FebuxostatAlleviatesAllergicRhinitis by Inhibiting Inflammation and Monocyte Adhesion in Human Nasal Epithelial Cells via Regulating KLF6. Evidence-based Complementary and Alternative Medicine, 2022 (PubMed: 36118091)

Application: WB    Species: Human    Sample: hNECs

Figure 2 The expression level of chemokines, adhesion molecules, and KLF6 expression in histamine-treated hNECs were repressed by febuxostat. (a). The expression level of chemokines was measured by the RT-qPCR assay, (b) the production of chemokines was evaluated by the ELISA assay, (c) the expression level of CAMs was checked by the RT-qPCR assay, (d) the expression level of CAMs was measured by the Western blotting assay (p < 0.05 and p < 0.01), (e) the adhesion between hNECs and U937 monocytes was inhibited by febuxostat. The attached U937 monocytes were detected using the calcein-AM staining assay (p < 0.05 and p < 0.01), (f) the expression level of KLF6 was evaluated by the RT-qPCR assay, and (g) the expression level of KLF6 was determined by the Western blotting assay (p < 0.05 and p < 0.01). Immunofluorescence magnification was 10×.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.